Related Experiment Video
Updated: Jun 14, 2025
07:55
Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
Published on: August 4, 2011
11.8K
Retinal Gliovascular Proliferation Secondary to Retinoblastoma Treated With Radiotherapy
Ophthalmic Surgery, Lasers & Imaging Retina
|September 4, 2024
Summary
Secondary retinal gliovascular proliferation (RGVP) can occur after retinoblastoma treatment. This benign lesion requires differentiation from tumor relapse, with treatments like laser photocoagulation showing positive outcomes.
Area of Science:
- Ophthalmology
- Oncology
- Retinal Diseases
Background:
- Retinal gliovascular proliferation (RGVP) is a benign retinal lesion.
- It can be idiopathic or secondary to other conditions.
- This study focuses on RGVP secondary to treated retinoblastoma.
Purpose of the Study:
- To describe the clinical features, treatment, and outcomes of secondary RGVP in patients with previously treated retinoblastoma.
- To differentiate this benign condition from late local relapse of retinoblastoma.
Main Methods:
- Retrospective review of clinical records from 1975-2022.
- Identified seven eyes of six patients with secondary RGVP overlying regressed retinoblastoma.
- Analyzed clinical features, treatment strategies, and patient outcomes.
Main Results:
- Secondary RGVP occurred in patients with completely regressed retinoblastoma, often near radiation-induced changes.
- Lesions presented as raised areas with telangiectasis, subretinal fluid, or hemorrhage.
- Treatment, including laser photocoagulation and anti-VEGF injections, led to lesion regression; untreated lesions remained stable.
Conclusions:
- Secondary RGVP is an occasional finding in patients with previously irradiated and regressed retinoblastoma.
- It is crucial to distinguish RGVP from a late local relapse of retinoblastoma.
- The findings support that RGVP is a distinct entity from retinoblastoma recurrence.
